H35.169 Retinopathy of prematurity, stage 5, unspecified eye

Name of the Condition

• Retinopathy of prematurity, stage 5, unspecified eye

Summary

Retinopathy of prematurity (ROP) stage 5, unspecified eye, is the most severe form of the condition, characterized by total retinal detachment in an unspecified eye. This stage results from progressive abnormal blood vessel growth and scarring in the retina of premature infants, leading to complete separation of the retina from the underlying tissue. Vision loss is typically severe and often permanent without intervention.

Causes

ROP stage 5 develops as a progression of the disease, driven by incomplete retinal vascularization in premature infants. The retina, which normally matures by full-term birth, may fail to develop adequate blood vessels in preterm infants. Factors such as oxygen therapy, fluctuations in oxygen levels, and the infant's overall immaturity contribute to abnormal vessel growth, which can advance to total retinal detachment in severe cases.

Risk Factors

• Prematurity (especially infants born before 28 weeks of gestation).
• Very low birth weight (typically under 1000 grams).
• Prolonged oxygen therapy or unstable oxygen levels during neonatal care.
• Multiple births (e.g., twins or triplets).
• Severe systemic illness or infections in the neonatal period.

Symptoms

Stage 5 ROP often presents with profound vision loss in the affected eye. Visible signs may include a white pupil (leukocoria) due to retinal detachment, abnormal eye movements, or a lack of visual response. Infants may also show signs of discomfort or irritability related to the condition.

Diagnosis

Diagnosis is confirmed through a comprehensive eye examination, typically performed by a pediatric ophthalmologist. This includes indirect ophthalmoscopy to assess retinal detachment and may involve imaging studies like ultrasound if the view is obscured. Staging follows standardized criteria to determine the extent of retinal involvement.

Treatment Options

Treatment focuses on preventing further progression and may include surgical interventions such as vitrectomy or scleral buckling to reattach the retina. In some cases, laser therapy or cryotherapy may be used to address underlying vascular abnormalities. Long-term management often involves visual rehabilitation and monitoring for complications.

Prognosis and Follow-Up

Prognosis is generally poor without intervention, as total retinal detachment often leads to permanent vision loss. Follow-up care is critical and may involve regular eye examinations, visual therapy, and support for developmental delays. Outcomes depend on the timing and success of treatment, as well as the infant's overall health.

Complications

Complications can include permanent blindness, amblyopia (lazy eye), strabismus (crossed eyes), and other visual impairments. Systemic issues like cerebral palsy or developmental delays may also occur, particularly in infants with severe prematurity or comorbidities.

Lifestyle & Prevention

Prevention focuses on optimizing neonatal care, including careful management of oxygen levels and early screening for ROP in high-risk infants. Supportive care for premature infants, such as nutritional support and infection prevention, may reduce the risk of severe disease progression.

When to Seek Professional Help

Seek immediate medical attention if an infant shows signs of vision loss, abnormal eye appearance, or unexplained irritability. Early evaluation by a pediatric ophthalmologist is essential for timely diagnosis and intervention.

Tips for Medical Coders

Use H35.169 for retinopathy of prematurity, stage 5, unspecified eye. Document the eye laterality as "unspecified" when the specific eye is not identified or documented. Ensure clinical correlation with the severity of retinal detachment and stage of ROP.